吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jun 14 2023

Full Issue

Congressional Calls Grow To Rein In PBM Business Tactics

During a House Oversight Committee hearing Tuesday, Chairman James Comer, a Republican from Kentucky, spoke out in favor of breaking up PBMs. On the other end of Capitol Hill, Sen. Bernie Sanders pushes NIH to reinstate a measure that requires reasonable drug pricing when a pharmaceutical company licenses NIH inventions.

A key House Republican ramped up his criticism of pharmacy benefit managers Tuesday, calling for the government to dismantle companies that have consolidated drug supply chain operations. (Wilkerson, 6/13)

In another bid to lower prescription drug prices, U.S. Sen. Bernie Sanders (I-Vt.) issued a report showing that medicines developed with help from the National Institutes of Health have often cost Americans more than what is paid in other countries. And he called on the agency to reinstate a provision in federal law that would require companies to set reasonable prices when they license NIH inventions. (Silverman, 6/13)

On artificial intelligence in health care 鈥

Lawmakers are beginning to consider ways in which artificial intelligence systems are involved in inventive processes like discovery of new drugs, and how the use of such technologies affects what is, and is not, patentable. (Ratnam, 6/13)

Delegates voted Monday聽to study the benefits and unforeseen circumstances of A.I., including large language models such as聽GPTs and other intelligence-generated medical content, and propose appropriate state and federal regulations, according to AMA documents. In those documents, A.I. is defined as augmented intelligence, a type of technology that still requires human involvement.聽(Hudson, 6/13)

On the federal and state push for gun control 鈥

Rep. Jamie Raskin (D-Md.) defended the Biden administration鈥檚 restriction on pistol braces and rejected arguments from Republicans who claim it violates the Second Amendment, saying, 鈥淲e don鈥檛 want them to repeal the Second Amendment. We want them to read the Second Amendment.鈥 Raskin argued that his Republican colleagues repeatedly invoke the second half of the Second Amendment, describing the right to keep and bear arms, but gloss over the first half that says, 鈥渁 well regulated militia, being necessary to the security of a free state.鈥 (Fortinsky, 6/13)

The Maine聽House of Representatives defeated a measure Tuesday to enshrine a 72-hour waiting period before gun purchases. Maine sticks out nationally as a Democratic-controlled state with a strong hunting culture that combines loose gun laws聽and聽 high levels of gun ownership聽with lower levels of gun mortality, although federal data from 2021 showed the latter was the highest in New England. Voters in 2016 rejected a referendum on mandatory background checks on private gun sales. (Kobin, 6/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
  • Friday, July 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF